RM

Rinkal Mayurbhai Gajera

Active Director Director DIN 11330730
DIN 11330730 First appointment Oct 2025 Primary industry Paper
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Rinkal Mayurbhai Gajera

Data last updated:

Rinkal Mayurbhai Gajera is a Director at Arogyo Pharma Private Limited (since 2025). The company operates in Paper.

DIN 11330730
Primary Designation Director
Industry Paper
First Appointment 08 Oct 2025
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Arogyo Pharma Private Limited U21001GJ2024PTC148344
Director08 Oct 20252024Active

Board colleagues of Rinkal Mayurbhai Gajera

Directorship timeline

Open interactive timeline →
Arogyo Pharma Private Limited
Premium access

Shareholding and investment profile for Rinkal Mayurbhai Gajera

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rinkal Mayurbhai Gajera

Rinkal Mayurbhai Gajera currently holds 1 directorship: Arogyo Pharma Private Limited (Director, since 08 Oct 2025).

Rinkal Mayurbhai Gajera was first appointed on 08 Oct 2025 as Director at Arogyo Pharma Private Limited.

The current boards of Rinkal Mayurbhai Gajera's companies include Ashim Kumar Sarkar (Arogyo Pharma Private Limited), Mayurkumar Mansukhbhai Gajera (Arogyo Pharma Private Limited), Shyamoli Ghosh (Arogyo Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available